Please let me know the short and long term outlook for Aurbindo Pharma purchased at ₹397 and Alembic Pharma at ₹197.
Kunal Gupta
Aurobindo Pharma (₹490.4): The stock decisively broke out of a key resistance at ₹200 in October 2013 and started to accelerate. Since then, it has been gaining more than 150 per cent. It conclusively breached its significant long-term resistance at ₹265 in November. After registering a new high at ₹536 on February 7, the stock has begun to slow.
You are sitting on a comfortable 23 per cent gain at this juncture. It is advisable to take profits off the table. Indicators in the daily chart are displaying a negative divergence implying trend reversal is on the cards. Therefore, we can't rule out a short-term corrective downtrend to ₹410 or ₹375 levels. Next important support is pegged at ₹300. The stock has key immediate resistance at ₹500. A strong rally above this level can take the stock higher to ₹550. As long as it trades above the ₹250 to ₹265 support band, its long-term trend remains bullish.
Alembic Pharmaceuticals (₹231.8): The stock has been on a long-term uptrend from its early 2012 low at ₹34. Even its medium-term trend is up. But the stock's short-term trend has been sideways in the band between ₹190 and ₹240 from November 2013. The stock is finding difficulty in breaking out the key resistance at ₹240. Moreover, the indicators are displaying negative divergence signalling a potential trend reversal. Hence, you can consider booking your 17 per cent gains in this stock at this juncture. Inability to surpass ₹240 will bring the stock down to its lower boundary at ₹190 in the medium term, which will erode your profits. The stock has immediate base at ₹210. Significant supports below ₹190 are placed at ₹170 and then at ₹130. A decisive fall below ₹130 will mar the medium-term uptrend and bring the stock down to ₹100. But an upward breakthrough of ₹240 can take it to new highs at ₹260.
Request one year technical outlook for Maruti Suzuki.
Panini Deshpande
Maruti Suzuki India (₹1,643.3): After spending a brief time period above the significant long-term resistance zone between ₹1,750 and ₹1,775 during December 2013 and January, the stock nose-dived in late January. This resistance zone is therefore a significant level. Since September 2012, the stock has been on a wide sideways consolidation phase between ₹1,250 and ₹1,775. Only a decisive breakout of the upper boundary will signal a bullish outlook and take it higher to ₹1,900 or to ₹2,000 in the long-term. But, failure to move above ₹1,775 will confine the stock to moving in this range for the next one year. Key immediate supports are positioned at ₹1,550. A strong decline below this support will reinforce bearish momentum and drag the stock down to its next support at ₹1,400 in the medium term.
I am holding shares of Helios and Matheson purchased at ₹116 and Biocon at ₹417. Kindly advise the technical outlook.
Murugesan
Helios & Matheson Information Technology (₹125.5): Since taking support at ₹35 in March 2013, the stock has been on a long-term uptrend, shaping higher peaks and trough. The medium-term trend is also up. However, the short-term trend is under threat. After encountering the long-term resistance in the band between ₹135 and ₹140 last week, the stock started to decline. Further, the indicators in the weekly chart are displaying a prolonged negative divergence since November 2013.
An emphatic drop below the immediate support at ₹120 will drag the stock down to ₹110 and then to ₹100. Therefore, you can book the minor profits available and exit the stock at current levels. Further, a strong decline below ₹100 will mitigate the medium-term uptrend and pull the stock down to ₹85. Only a conclusive breakthrough of the long-term resistance band between ₹135 and ₹140 will strengthen the uptrend and take it upwards to the ₹160 to ₹170 range. But, this break out is unlikely in the short-term as the indicators are signifying that the trend reversal is on the cards.
Biocon (₹427): After encountering a key resistance at ₹485 in December 2013 and again in January 2014, the stock changed its trend. It started to decline and has been on a short-term downtrend.
The stock is moving sideways around the immediate support level at ₹420. A fall below this support will drag the stock down to ₹400 and then to ₹380. Exit the stock and re-enter at the key support level at ₹380. Subsequent long-term support below ₹380 is at ₹350. On the other hand, ₹500 is the key resistance after the immediate resistance at ₹455.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.